Asthma drugs cut risk of CVD

Some asthma medications might help reduce cardiovascular risk and alleviate asthma symptoms, a US study has shown.

It found patients given low-dose theophylline add-on therapy or the leukotrine receptor antagonist montelukast for asthma had lower cardiovascular disease blood risk factors.

Both drugs are recommended by British Thoracic Society/SIGN guidelines for asthma patients who do not respond to long acting beta-2 agonists.

The study included 489 patients aged from 15-79 years who were diagnosed with asthma, but had an FEV1 greater than 50 per cent.

Dr Steve Holmes, Somerset GP and General Practice Airways Group (GPIAG) chairman said: 'This study looked very much at surrogate markers rather than actual outcomes.'

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Just published

Closed sign

GP contract changes 'could lead to more practice closures'

Changes to the GP contract for 2023/24 could lead to more practice closures and more...

Talking General Practice

Podcast: Will GPs take industrial action, patientsā€™ views on the NHS, junior doctor dispute

The team looks at whether GPs will be prepared to take industrial action and the...

GP at desk

GPs to 'exception report' appointments booked over two weeks ahead

GP practices will be able to 'exception report' appointments booked deliberately...

GP sign

Contract update hands practices just six weeks to agree access improvement plans

GP practices have just six weeks to agree access improvement plans covering patient...

GP appointment

GP anger over last-minute release of contract detail for 2023/24

GP leaders have hit out at NHS England after it waited until just two days before...

GP consulting room

GP appointments surge 10% above pre-pandemic level

GP practices in England delivered 10% more appointments in February this year compared...